| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181012 Method for detecting regulatory t cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the compostion |
| 07/16/2009 | US20090181000 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 07/16/2009 | US20090180998 Methods of isolating non-senescent cardiac stem cells and uses thereof |
| 07/16/2009 | US20090180990 Composition for maintaining healthy kidney function |
| 07/16/2009 | CA2711807A1 Agonists for antimicrobial peptide systems |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711408A1 Trpa1 antagonists |
| 07/16/2009 | CA2708921A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 07/15/2009 | EP2078525A2 Treatment of tuberculosis using immunomodulator compounds |
| 07/15/2009 | EP2078004A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 07/15/2009 | EP2077902A2 Use of nutritional compositions for preventing disorders |
| 07/15/2009 | EP1662908B1 Composition and method for facilitating bone healing |
| 07/15/2009 | EP1653989B1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | EP1446099B1 Injectable depot composition |
| 07/15/2009 | EP1370268B1 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1261335B1 Combination of n-acetyl-l-tryptophan and magnesium sulphate for the treatment of brain, spinal and nerve injury |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | CN101484187A Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN101480376A Method of preparing particles for agglomeration |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100512813C Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560493 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/14/2009 | US7560449 Methods and therapeutic combinations for the treatment of demyelination |
| 07/14/2009 | US7560447 For oral administering; polyunsaturated fatty acid, phospholipids and controller of methionine metabolism such as folic acid, vitamins, minerals and zinc; Alzheimer'sdisas |
| 07/14/2009 | US7560443 Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560122 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/14/2009 | US7560103 Administering hapten modified syngeneic human tumor cell substantially in a no growth phase and an adjuvant for therapy of cancer |
| 07/14/2009 | US7560101 Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A |
| 07/14/2009 | CA2649740A1 Therapies for cognition and learning enhancement |
| 07/14/2009 | CA2503718C Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 07/14/2009 | CA2472392C Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/14/2009 | CA2439858C Graft rejection suppressors |
| 07/14/2009 | CA2390092C Solid dispersion pharmaceutical formulations |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/14/2009 | CA2306560C Topical antifungal composition |
| 07/09/2009 | WO2009084732A1 Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy |
| 07/09/2009 | WO2009084693A1 Antitumor agent |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084588A1 Water-containing composition which can be used as external composition |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084200A1 External skin preparation for pimpled skin |
| 07/09/2009 | WO2009083759A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | WO2009083643A2 Composition for treating sterile inflammation |
| 07/09/2009 | WO2009083521A2 Antibacterial compositions comprising an antiseptic in combination with an antibiotic |
| 07/09/2009 | WO2009082819A1 Novel lupane derivatives |
| 07/09/2009 | WO2009082818A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | WO2009024889A3 Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176874 Tnp-470 polymer conjugates and use thereof |
| 07/09/2009 | US20090176866 Complexes having adjuvant activity |
| 07/09/2009 | US20090176848 Fortifier |
| 07/09/2009 | US20090176814 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176800 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/09/2009 | US20090176751 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176704 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176206 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 07/09/2009 | US20090175832 Isolated Embryonic-Like Stem Cells Derived From Human Umbilical Cord Blood |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | US20090175793 Treatment of male sexual dysfunction |
| 07/09/2009 | CA2711424A1 Novel lupane derivatives |
| 07/09/2009 | CA2711420A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | CA2711211A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | CA2710740A1 Antitumor agent |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077266A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 07/08/2009 | EP2077122A1 Therapeutic agents for irritable bowel syndrome |
| 07/08/2009 | EP2077114A1 Pharmaceutical preparation for treating fibromyalgia |
| 07/08/2009 | EP2077107A1 Calcium-containing structures and methods of making and using the same |
| 07/08/2009 | EP2076289A2 Methods for treating cancer resistant to erbb therapeutics |
| 07/08/2009 | EP2076288A2 Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| 07/08/2009 | EP2076265A2 Ketoconazole enantiomer in humans |
| 07/08/2009 | EP2076254A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 07/08/2009 | EP2076239A1 Combination therapy |
| 07/08/2009 | EP1735002B1 Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1489169B1 Sumoylation inhibitors |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |